BA
Dartmouth College
1986-1990
Dr. Quyen D. Chu is a board-certified surgical oncologist and the Roy L. Schneider Endowed Professor of Surgery at Howard University Hospital and College of Medicine. He has over 20 years of surgical experiences, specializing in the following cancers: Gastrointestinal tract (pancreas, liver, bile duct, esophagus, stomach, small bowel, colon/rectum), sarcoma (intra-abdominal, extremity), skin cancers (melanoma, squamous/basal cell carcinoma), cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), recurrent/advanced solid tumors. Dr. Chu also serves as Chief of Surgical Oncology and Associate Director of Cancer Center for Howard University College of Medicine.
Dr. Chu earned his bachelor degree from Dartmouth College, Hanover, New Hampshire, medical degree at the Brown University School of Medicine in Providence, Rhode Island, and completed an internship in general surgery at Baystate Medical Center in Springfield, Massachusetts. His residency in general surgery was performed at St. Elizabeth’s Medical Center in Boston, where he also served as chief resident. He was a research fellow in the surgery department at Brown and completed a clinical fellowship in surgical oncology at Roswell Park Cancer Institute in Buffalo, New York. He also received his Executive MBA at Centenary College, Shreveport Louisiana. He was appointed by President Barack Obama in 2013 to be on the Vietnam Education Foundation (VEF) Board. He has taken multiple international trips to countries such as Vietnam, Kurdistan (Iraq), and Nicaragua. He was the recipient of the ASCO Humanitarian Award, the AHPBA Humanitarian Award, and the Charles Black Humanitarian Award.
Dr. Chu has published over 230 peer-reviewed papers/abstracts, 30 book chapters, and chief editor of two major textbooks: (1) Surgical Oncology: A Practical and Comprehensive Approach 2014 and (2) Hepato-Pancreato-Biliary and Transplant Surgery:Practical Management of Dilemmas: Beaux Books 2018. He was a co-editor of AHPB. The First 25 Years and was an author of the Mastery of Surgery series.
He is an active member of several organizations such as the ASCO (Past Program Director of the Oncology Training Program in Vietnam), ASCO University Associate Editor, American Hepato-Pancreato-Biliary Association (AHPBA), International Hepato-Pancreato-Biliary Association (IHPBA), Southern Surgical Association, Society of University Surgeons, and American College of Surgeons. He currently serves as President of the Surgical Association of Louisiana, Louisiana CoC State Chair, CoC Committee member, Chair of the Education, Quality and Communications Subcommittee of the International Relations Committee of the ACS, SESAP committee, Publication Committee for AHPBA, and Selection Committee for the American College of Surgeons General Surgery Health Policy Scholars for 2016. Dr. Chu has won several awards including the ASCO Leadership Development Program, ACS Japan Traveling Award, the AHPBA Traveling Award, the Ellis-Island Medals of Honor, and Presidential Leadership Scholars Award.
Dartmouth College
1986-1990
Brown University School of Medicine
1990-1994
Centenary College
2011-2013
Over 20 years of surgical experiences, specializing in the following cancers: Gastrointestinal tract (pancreas, liver, bile duct, esophagus, stomach, small bowel, colon/rectum), sarcoma (intra-abdominal, extremity), skin cancers (melanoma, squamous/basal cell carcinoma), cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC), recurrent/advanced solid tumors.
1. Agency: Feist-Weiller Cancer Grant Amount: $20,000
Title: The Role of Gene Therapy in a Rat Peritoneal
Carcinomatosis Model
Role: Principal Investigator Effort: 20%
Period of Grant: 1/06-1/07
2. Agency: Susan G. Komen Foundation Amount: $95,436
Title: Patient Navigation Program for Breast Cancer
Role: Principal Investigator Effort: 10%
Period of Grant: 4/09-3/2010
3. Agency: Vietnam Education Foundation Amount: $55,000
Title: Fundamentals of General Surgery
Role: Principal Investigator Effort: 20%
Period of Grant: 9/09-6/2010
4. Agency: LA Gene Therapy Consortium Amount: $25,000
Title: CRAd-CXCR4-UTR-E1a.Fiber5/3s in In Vitro
and In Vivo Model of Pancreatic Cancer
Role: Principal Investigator Effort: 10%
Period of Grant: 7/09-6/2010
5. Agency: Pharmaceutical Companies Amount: $13,000
Title: 16th Annual Carroll W. Feist Scientific Symposium
on Hepatocellular Carcinoma
Role: Program Director Effort: 20%
Period: 7/17/2009
6. Agency: Pharmaceutical Companies Amount: $14,000
Title: 1St Annual Regional Hepato-Pancreato-Biliary
Symposium on Pancreatic Carcinoma
Role: Program Director Effort: 20%
Period: 11/20/2009
7. Agency: Pharmaceutical Companies Amount: $14,000
Title: 17th Annual Carroll W. Feist Scientific Symposium
on Esophageal Carcinoma
Role: Program Director Effort: 20%
Period: 7/23/2010
8. Agency: Department of Defense Amount: $75,000
Title: Integrin (α6β4) Regulation of Lipid Rafts Signaling
Role: Co-Investigator Effort: 20%
Period: 5/2010 through 5/2011
9. Agency: Vietnam Education Foundation Amount: $55,000
Title: Multidisciplinary Approach in Managing
Breast Cancer
Role: Principal Investigator Effort: 20%
Period: 10/25/2010-3/31/2011
10. Agency: R01 CA 112282-06A1
Title: The Role of CDC25A in Breast Cancer
Role: Co-Investigator Effort: 5%
PI: Hiroaki Kiyokawa, Ph.D. Amount: $1,375,937
Period: 7/1/11-6/30/13
Appointed by President Barack Obama in 2013 t